Stay updated on Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial
Sign up to get notified when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.

Latest updates to the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study page now indicates that it is no longer recruiting participants, signaling that enrollment is closed. New navigation and guidance sections such as How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment heading were added, reflecting a reorganization and improved user guidance.SummaryDifference0.5%

- Check21 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, reflecting a small update to the page's content.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a maintenance update to the document or site component. This reflects an internal change rather than an alteration to user-facing content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page shows a revision tag updated to v3.5.3, replacing the previous v3.5.2. This reflects a minor update to the ClinicalTrials.gov entry without altering core study information.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.5.2 is now displayed, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check85 days agoChange DetectedScreenshots show no visible additions or deletions; page content appears unchanged between versions.SummaryDifference0.1%

Stay in the know with updates to Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.